Business Standard
Tuesday, May 29, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
 

Lupin Pharma receives US nod for heart drug
Press Trust of India / Mumbai Jan 29, 2010, 12:42 IST

Pharma firm Lupin today said its US-based subsidiary Lupin Pharmaceuticals Inc has received approval from the US drug regulator for Perindopril Erbumine tablets, used in treatment of heart disease.

The company has received final approval from the US Food and Drug Administration (US FDA) for its Perindopril Erbumine tablets in the strengths of 2mg, 4mg and 8mg, Lupin said in a statement to the Bombay Stock Exchange.

BSE | NSE
Price  
lupin
According to Mumbai-based drug manufacturer, "commercial shipments of the product will commence shortly."

The tablets are indicated for the treatment of patients with essential hypertension and can be used with conventional treatment for management of coronary artery disease, it said.

Headquartered in Baltimore, Lupin Pharmaceuticals Inc is the US wholly-owned subsidiary of Lupin Ltd.

Shares of Lupin were trading at Rs 1,397, down 0.76 per cent on BSE.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end on a strong note
- Nabard FY14 operating surplus soars 28% to Rs 1,635 cr
- RBI eases banks' term deposit restrictions
- NMDC Q4 net down 21.74% to Rs 1,642.28 cr
- Balrampur Chini Q4 profit up by 15%
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- 2 Lac Apartments, 1 Lac House / Plots. Click here
- Help a Child Achieve her. Click to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- A Brand New Server at a Price That Fits Your Budget. Click here
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Re fall has minor impact on India?s rating, says Moody?s
- No diesel price hike for now, says Reddy
- IPL victory puts KKR in the black
- From virtual world, hacktivism spills into real world
- Air India board refers Boeing compensation issue to govt
 
 More  
Tax Shastra
  Now available at Special price
  Rs. 360/- Only

  Buy Now
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us